| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P819 | ADS bibcode | 2015PLoSO..1016517X |
| P356 | DOI | 10.1371/JOURNAL.PONE.0116517 |
| P932 | PMC publication ID | 4339736 |
| P698 | PubMed publication ID | 25710884 |
| P5875 | ResearchGate publication ID | 272842147 |
| P2093 | author name string | Hui Xu | |
| Kan Wang | |||
| Baozhong Liu | |||
| Shang Xie | |||
| Xiaofeng Shan | |||
| Zhigang Cai | |||
| P2860 | cites work | Control of apoptosis and mitotic spindle checkpoint by survivin | Q22008570 |
| Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis | Q24289436 | ||
| A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma | Q24322614 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. | Q51739552 | ||
| Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan. | Q53357514 | ||
| Differential subcellular localization of functionally divergent survivin splice variants. | Q53384616 | ||
| Expression of survivin messenger RNA correlates with poor prognosis in patients with hepatocellular carcinoma. | Q53392249 | ||
| Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. | Q53465124 | ||
| Oral Cancer | Q56603649 | ||
| Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma | Q57215937 | ||
| Surgery alone for squamous cell carcinoma of the oral cavity: survival rates, recurrence patterns, and salvage treatment | Q58187335 | ||
| Expression of survivin and its relationship to loss of apoptosis in breast carcinomas | Q73404059 | ||
| Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas | Q74530673 | ||
| Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers | Q79219271 | ||
| High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy | Q79449836 | ||
| Evaluating expression and potential diagnostic and prognostic values of survivin in bladder tumors: a preliminary report | Q80549025 | ||
| Expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue | Q85659085 | ||
| Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies | Q24802579 | ||
| P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study | Q24812605 | ||
| Prognostic role of survivin in bladder cancer: a systematic review and meta-analysis | Q27028122 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Cancer statistics, 2014 | Q27861018 | ||
| Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses | Q28131633 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting | Q28268610 | ||
| Targeting survivin in cancer therapy | Q28273083 | ||
| IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs | Q28291174 | ||
| Survivin splice variants regulate the balance between proliferation and cell death | Q28305497 | ||
| Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses | Q33372680 | ||
| Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis | Q34212175 | ||
| Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis | Q34427388 | ||
| Oral cancer prevention and control--the approach of the World Health Organization | Q34597352 | ||
| Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis | Q34766411 | ||
| Control of apoptosis during angiogenesis by survivin expression in endothelial cells | Q35745355 | ||
| Unbalanced alternative splicing and its significance in cancer | Q36425627 | ||
| Survivin expression in oral squamous cell carcinoma. | Q36673589 | ||
| Survivin expression and targeting in breast cancer. | Q37844950 | ||
| Role of survivin as prognostic and clinicopathological marker in gastric cancer: a meta-analysis | Q38129225 | ||
| Survivin expression correlates with nodal metastasis in T1-T2 squamous cell carcinoma of the tongue. | Q38199996 | ||
| Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance | Q39651833 | ||
| Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma | Q39755799 | ||
| Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker | Q40163909 | ||
| Survivin expression is significantly higher in pN+ oral and oropharyngeal primary squamous cell carcinomas than in pN0 carcinomas. | Q42487953 | ||
| Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma | Q42959413 | ||
| Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis | Q43704191 | ||
| A study on survival rates of oral squamous cell carcinoma | Q43721672 | ||
| Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis | Q44529268 | ||
| Clinical significance of Cox-2, Survivin and Bcl-2 expression in hepatocellular carcinoma (HCC). | Q44962896 | ||
| Detection of survivin mRNA in healthy oral mucosa, oral leucoplakia and oral cancer. | Q46526147 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| oral squamous cell carcinoma | Q18553522 | ||
| P304 | page(s) | e0116517 | |
| P577 | publication date | 2015-02-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis | |
| P478 | volume | 10 |
| Q58567065 | Association of Resistin Gene Polymorphisms with Oral Squamous Cell Carcinoma Progression and Development |
| Q91594680 | Contribution to characterization of skin field cancerization activity: morphometric, chromatin texture, proliferation, and apoptosis aspects |
| Q33732980 | EMODIN DOWNREGULATES CELL PROLIFERATION MARKERS DURING DMBA INDUCED ORAL CARCINOGENESIS IN GOLDEN SYRIAN HAMSTERS. |
| Q52911914 | Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines. |
| Q35756622 | Efficacy and safety of botulinum toxin type A for treatment of Frey's syndrome: evidence from 22 published articles |
| Q28067438 | Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis |
| Q36014355 | FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma. |
| Q58772889 | Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma |
| Q33798379 | High TGF-β1 expression predicts poor disease prognosis in hepatocellular carcinoma patients |
| Q42223242 | Impact of CCL4 gene polymorphisms and environmental factors on oral cancer development and clinical characteristics. |
| Q57764673 | Integrative Histologic and Bioinformatics Analysis of BIRC5/Survivin Expression in Oral Squamous Cell Carcinoma |
| Q93386603 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer |
| Q26796553 | PRISMA-Extracapsular Dissection Versus Superficial Parotidectomy in Treatment of Benign Parotid Tumors: Evidence From 3194 Patients |
| Q47308433 | Resistance of oral cancer cells to 5-ALA-mediated photodynamic therapy. |
| Q52674600 | Roles of flotillins in tumors. |
| Q36512594 | Survivin Modulates Squamous Cell Carcinoma-Derived Stem-Like Cell Proliferation, Viability and Tumor Formation in Vivo. |
| Q33634679 | Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma. |
| Q36275252 | Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma |
| Q33626354 | YM155 Down-Regulates Survivin and Induces P53 Up-Regulated Modulator of Apoptosis (PUMA)-Dependent in Oral Squamous Cell Carcinoma Cells |
Search more.